Ozempic and Mounjaro usually have a strong chance of approval when a patient has type 2 diabetes, says Joseph Zucchi, a physician associate and clinical supervisor at Transition Medical Weight Loss, a medical weight loss center in Salem, New Hampshire
Weight Watchers integrated model has demonstrated real-world outcomes for people using GLP-1 medications
Therefore, it is recommended to start the medication at a very low dose (1 mg or 2 mg) to help your body adjust, improve tolerance, and reduce the risk of side effects
In a 52 week Phase 2 trial, overweight/obese individuals without diabetes lost 13.7% of their body weight (placebo subtracted) after receiving maridebart cafraglutide (420 mg once monthly), and overweight/obese individuals with diabetes lost 10.6% of their body weight and saw a decrease in HbA 1c of ~17 mmol/mol (1.5%, placebo subtracted) after receiving maridebart cafraglutide at the same dose (Table 2) [55]
Lipotropic injections work best for patients who: Want metabolic and energy support alongside a healthy lifestyle Are not seeing progress with diet and exercise alone Prefer a non-surgical wellness approach Are committed to a consistent treatment schedule A consultation with a qualified provider is the best way to determine whether lipotropic injections are appropriate for your specific goals
This is where the discussion becomes particularly interesting